Search Within

Ross Levine

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (26)
  2. Meeting Abstract (16)
Groups
  1. Adult Leukemia (42)
  2. Center for Hematologic Malignancies (42)
  3. Department of Medicine (42)
  4. Executive Committee, Center for Hematologic Malignancies (42)
  5. GSK Faculty (42)
  6. Hematologic Malignancies, Division of (42)

More Groups

People
  1. Gabriela Chiosis (14)
  2. Omar Abdel-Wahab (14)
  3. Mithat Gonen (13)
  4. Ly Vu (11)
  5. Martin Tallman (11)
  6. Tony Taldone (10)

More People

Years
  1. 2024 (1)
  2. 2019 (1)
  3. 2018 (2)
  4. 2017 (4)
  5. 2016 (6)
  6. 2015 (11)

More Years

Publications
  1. Blood (15)
  2. Cancer Discovery (2)
  3. Cancer Research (2)
  4. Journal of Clinical Investigation (2)
  5. Nature (2)
  6. Nature Medicine (2)

More Publications

Publishers
  1. American Society of Hematology (15)
  2. Nature Publishing Group (9)
  3. American Association for Cancer Research (5)
  4. American Society for Clinical Investigation (2)
  5. Cell Press (2)
  6. Massachusetts Medical Society (2)

More Publishers

Results (42)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting mutant BRAF in relapsed or refractory hairy-cell leukemia
    Journal Article

    Tiacci, E.; Park, J. H.; De Carolis, L.; Chung, S. S.; Broccoli, A.; Scott, S.; Zaja, F.; Devlin, S.; Pulsoni, A.; Chung, Y. R.; more...
    New England Journal of Medicine (2015)

    Fulltext@MSK | Save
  • Loss of BAP1 function leads to EZH2-dependent transformation
    Journal Article

    LaFave, L. M.; Béguelin, W.; Koche, R.; Teater, M.; Spitzer, B.; Chramiec, A.; Papalexi, E.; Keller, M. D.; Hricik, T.; Konstantinoff, K.; more...
    Nature Medicine (2015)

    Fulltext@MSK | Save
  • In support of a patient-driven initiative and petition to lower the high price of cancer drugs
    Journal Article

    Tefferi, A.; Kantarjian, H.; Rajkumar, S. V.; Baker, L. H.; Abkowitz, J. L.; Adamson, J. W.; Advani, R. H.; Allison, J.; Antman, K. H.; Bast, R. C. Jr; more...
    Mayo Clinic Proceedings (2015)

    Fulltext@MSK | Save
  • The polycomb group protein L3MBTL1 represses a SMAD5-mediated hematopoietic transcriptional program in human pluripotent stem cells
    Journal Article

    Perna, F.; Vu, L. P.; Themeli, M.; Kriks, S.; Hoya-Arias, R. ; Khanin, R.; Hricik, T.; Mansilla-Soto, J.; Papapetrou, E. P.; Levine, R. L.; more...
    Stem Cell Reports (2015)

    Fulltext@MSK | Save
  • Musashi2 sustains the mixed-lineage leukemia-driven stem cell regulatory program
    Journal Article

    Park, S. M.; Gönen, M.; Vu, L.; Minuesa, G.; Tivnan, P.; Barlowe, T. S.; Taggart, J.; Lu, Y.; Deering, R. P.; Hacohen, N.; more...
    Journal of Clinical Investigation (2015)

    Fulltext@MSK | Save
  • Msi2 maintains the MLL leukemia stem cell regulatory program
    Meeting Abstract

    Park, S. M.; Gonen, M.; Vu, L. P.; Minuesa, G.; Tivnan, P.; Barlowe, T.; Taggart, J.; Lu, Y. H.; Deering, R. P.; Hacohen, N.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Vemurafenib has potent antitumor activity in patients with relapsed/refractory BRAF mutant hairy cell leukemia
    Meeting Abstract

    Park, J. H.; Chung, S. S.; Chung, Y. R.; Won, H.; Kim, E.; Saven, A.; Wadleigh, M.; Stone, R. M.; Barrientos, J. C.; Rai, K. R.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Genomic and functional analysis of leukemic transformation of myeloproliferative neoplasms
    Journal Article

    Rampal, R.; Ahn, J.; Abdel-Wahab, O.; Nahas, M.; Wang, K.; Lipson, D.; Otto, G. A.; Yelensky, R.; Hricik, T.; McKenney, A. S.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2014)

    Fulltext@MSK | Save
  • Efficacy of intermittent combined RAF and MEK inhibition in a patient with concurrent BRAF- and NRAS-mutant malignancies
    Journal Article

    Abdel-Wahab, O.; Klimek, V. M.; Gaskell, A. A.; Viale, A.; Cheng, D.; Kim, E.; Rampal, R.; Bluth, M.; Harding, J. J.; Callahan, M. K.; more...
    Cancer Discovery (2014)

    Fulltext@MSK | Save
  • Improved targeting of JAK2 leads to increased therapeutic efficacy in myeloproliferative neoplasms
    Journal Article

    Bhagwat, N.; Koppikar, P.; Keller, M.; Marubayashi, S.; Shank, K.; Rampal, R.; Qi, J.; Kleppe, M.; Patel, H. J.; Shah, S. K.; more...
    Blood (2014)

    Fulltext@MSK | Save